-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
AbCellera Biologics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
- AbCellera Biologics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$51.1M, a 78.6% decline year-over-year.
- AbCellera Biologics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$176M, a 36.1% decline year-over-year.
- AbCellera Biologics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$146M, a 192% decline from 2022.
- AbCellera Biologics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $159M, a 3.29% increase from 2021.
- AbCellera Biologics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $153M, a 29.1% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)